RCD advises AlbaJuna Therapeutics, an IrsiCaixa spin-off, on the inflow of capital that will fund the development of antibodies against HIV

by DWF-RCD

RCD – Rousaud Costas Duran has advised AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, on the investment of €3.75M by the pharmaceutical company Grifols, which will s...

Read more

Aelix Therapeutics completes Series A funding of € 11.5 M ($ 12.7 M)

by Caixa Capital Risc

The proceeds will support the development of the HTI immunogen as a therapeutic vaccine against HIV infection, up to the completion of a Phase 2 proof-of-concept efficacy trial in HIV-infected individ...

Read more
Subscribe to Directory
Write an Article

Highlight

Ardian crea el grupo MonBake tras cerrar...

by Ardian

Ardian, uno de los mayores fondos de inversión de Europa, cerró ayer...

LEM Loan eMarket prevé triplicar su ofe...

by LEM Loan eMarket

Con una cartera en comercialización compuesta por más de 5.000 créd...

Photos Stream